Concepedia

Kevin D. Courtney

KD

Statistics

Publications

39

Citations

4.4K

H-Index

27

Active since

1979

Affiliations

The University of Texas Southwestern Medical Center(Current)

Dana-Farber Cancer Institute

Harvard University

Southwestern Medical Center

Kevin D. Courtney is an author at The University of Texas Southwestern Medical Center specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1979–2025

39

Publications

39

Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Dimitrios Anastasiou, Yimin Yu, William J. Israelsen et al. · Nature Chemical Biology · 2012 · 825 citations · Full text

, , +15

Targeting renal cell carcinoma with a HIF-2 antagonist

Wenfang Chen, Haley Hill, Alana Christie et al. · Nature · 2016 · 723 citations

, , +10

Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma

Kevin D. Courtney, Jeffrey R. Infante, Elaine T. Lam et al. · Journal of Clinical Oncology · 2017 · 390 citations · Full text

, , +16

Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo

Kevin D. Courtney, Divya Bezwada, Tomoyuki Mashimo et al. · Cell Metabolism · 2018 · 298 citations · Full text

, , +14

Reduction of Chromium(VI) by Ascorbate Leads to Chromium-DNA Binding and DNA Strand Breaks in Vitro

Diane M. Stearns, Laura J. Kennedy, Kevin D. Courtney et al. · Biochemistry · 1995 · 234 citations

, , +10

1–5 of 39